Recent results with the MED-EL COMBI 40+ cochlear implant and TEMPO+ behind-the-ear processor.
Cochlear implantation is a viable treatment for patients with severe to profound hearing loss. We report the results of speech perception tests (numbers, monosyllables, and sentence tests) achieved with MED-EL's COMBI40+ (C40+) cochlear implant after 12 months of use. These findings, which were taken from a larger German study, were similar to those of other studies of the C40+ implant. We also compared the differences in speech perception observed with the CIS PRO+ body-worn speech processor and the newer TEMPO+ behind-the-ear speech processor. Although these results were similar with respect to most of the measured parameters, the TEMPO+ processor had a distinct advantage during tests in noise.
Anderson
Ilona
I
Clinical Research Department, MED-EL, Fürstenweg 77, Innsbruck 6020, Austria. i.anderson@medel.com
Weichbold
Viktor
V
D'Haese
Patrick
P
D000328:Adult; D000368:Aged; D003054:Cochlear Implants; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013063:Speech Discrimination Tests; D013067:Speech Perception; D016896:Treatment Outcome